What is VAXNEUVANCETM (Pneumococcal 15-Valent Conjugate Vaccine)?

VAXNEUVANCE is a vaccine that helps protect against some of the most common types of pneumococcal bacteria that can cause invasive pneumococcal disease (IPD).

How does VAXNEUVANCE help protect my baby from IPD?

The vaccine works by helping your child’s immune system fight against the bacteria.

The CDC recommends the use of VAXNEUVANCE as an option to help protect against IPD.

When should my child get VAXNEUVANCE?

Babies and toddlers need 4 doses of VAXNEUVANCE. That means one dose at:

2 months

Dose 1

4 months

Dose 2

6 months

Dose 3

12-15 months

Dose 4

Your child may get VAXNEUVANCE at the same time as they get other vaccines.

Don’t wait to vaccinate with VAXNEUVANCE.

Completing ALL 4 doses of VAXNEUVANCE can help give your baby the protection they need against IPD.

Find out what to expect after your baby is vaccinated.

Possible side effects

Learn about the Vaccines for Children (VFC) Program.

Vaccines for Children Program

What is VAXNEUVANCE?

VAXNEUVANCE is a vaccine to help protect against invasive disease caused by 15 types of pneumococcus (pronounced “noo-mo-ca-cus”), a kind of bacteria, in individuals 6 weeks of age and older. Invasive disease is a serious form of pneumococcal disease.

Important Safety Information

VAXNEUVANCE might not protect everyone who gets the vaccine.

 

Your child should not get VAXNEUVANCE, if your child is allergic to any of the ingredients in VAXNEUVANCE or allergic to diphtheria toxoid.

 

Before your child gets VAXNEUVANCE, tell your health care provider if your child has or had an allergic reaction to any vaccine. Tell your health care provider if your child has a weak immune system or takes medicines or treatments that might weaken the immune system. Tell your health care provider if your adolescent child is pregnant or breast-feeding. If your child is an infant, tell your health care provider if your child was born too early (prematurely).

 

The most common side effects seen in children less than 2 years of age are fever; pain, redness, swelling, or a lump where your child got the injection. Your child may be more fussy than usual, more sleepy than usual, and eating less than usual.

 

The most common side effects seen in children and adolescents 2 through 17 years of age are pain, swelling, redness or a lump where your child got the injection; muscle aches; feeling tired; and headache.

 

After getting VAXNEUVANCE, tell your health care provider right away if your child has symptoms of an allergic reaction, which may include difficulty breathing, swelling of the face, lips, tongue or throat, hives, or rash. Also tell your health care provider if your child has any side effects that become bothersome or if any other unusual symptoms develop.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please read the accompanying Patient Information for VAXNEUVANCE and discuss it with your health care provider. The physician Prescribing Information also is available.

What is VAXNEUVANCETM (Pneumococcal 15-valent Conjugate Vaccine)?

VAXNEUVANCE is a vaccine to help protect against invasive disease caused by 15 types of pneumococcus (pronounced “noo-mo-ca-cus”), a kind of bacteria, in individuals 6 weeks of age and older. Invasive disease is a serious form of pneumococcal disease.

VAXNEUVANCE is a vaccine to help protect against invasive disease caused by 15 types of pneumococcus

VAXNEUVANCE is a vaccine to help protect against invasive disease caused by 15 types of pneumococcus (pronounced “noo-mo-ca-cus”), a kind of bacteria, in individuals 6 weeks of age and older. Invasive disease is a serious form of pneumococcal disease.

Important Safety Information for VAXNEUVANCETM (Pneumococcal 15-valent Conjugate Vaccine)

VAXNEUVANCE might not protect everyone who gets the vaccine.

 

Your child should not get VAXNEUVANCE, if your child is allergic to any of the ingredients in VAXNEUVANCE or allergic to diphtheria toxoid.

 

Before your child gets VAXNEUVANCE, tell your health care provider if your child has or had an allergic reaction to any vaccine. Tell your health care provider if your child has a weak immune system or takes medicines or treatments that might weaken the immune system. Tell your health care provider if your adolescent child is pregnant or breast-feeding. If your child is an infant, tell your health care provider if your child was born too early (prematurely).

 

The most common side effects seen in children less than 2 years of age are fever; pain, redness, swelling, or a lump where your child got the injection. Your child may be more fussy than usual, more sleepy than usual, and eating less than usual.

 

The most common side effects seen in children and adolescents 2 through 17 years of age are pain, swelling, redness or a lump where your child got the injection; muscle aches; feeling tired; and headache.

 

After getting VAXNEUVANCE, tell your health care provider right away if your child has symptoms of an allergic reaction, which may include difficulty breathing, swelling of the face, lips, tongue or throat, hives, or rash. Also tell your health care provider if your child has any side effects that become bothersome or if any other unusual symptoms develop.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please read the accompanying Patient Information for VAXNEUVANCE and discuss it with your health care provider. The physician Prescribing Information also is available.

VAXNEUVANCE might not protect everyone who gets the vaccine.

VAXNEUVANCE might not protect everyone who gets the vaccine.

 

Your child should not get VAXNEUVANCE, if your child is allergic to any of the ingredients in VAXNEUVANCE or allergic to diphtheria toxoid.